CGRP ligand
Assets acting on this target.
- Class
- CGRP ligand inhibitor
By indication
Related mechanisms
CGRP ligand drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Eptinezumab (Vyepti)Vyepti | H. Lundbeck | monoclonal antibody | Approved | Approved in Migraine |
| Fremanezumab (Ajovy)Ajovy | NeuroGen Pharma, Otsuka Holdings, Teva Pharmaceutical Industries | antibody | Approved | Approved in Migraine |
| Galcanezumab (Emgality)Emgality | Daiichi Sankyo, Eli Lilly | monoclonal antibody | Approved | Approved in Migraine |